Tau PET correlates closely with cognitive decline in Alzheimer’s disease, making it a potential surrogate outcome measure. Yet in amyloid immunotherapy trials to date, this signal has not always ...

A team from the University of Geneva (UNIGE) and the Geneva University Hospitals (HUG) has demonstrated that tau PET -- a novel imaging technique for visualising the tau protein -- can predict ...

A new tau PET radiotracer, 18F-SNFT-1, has been found to be more effective than existing tau PET radiotracers in identifying Alzheimer’s disease in its earliest stages, according to research.

Two new PET radiotracers have outperformed the only current Food and Drug Administration (FDA) approved radiotracer for ...

A new tau PET radiotracer, 18 F-SNFT-1, has been found to be more effective than existing tau PET radiotracers in identifying Alzheimer's disease in its earliest stages, according to research ...

The new Centiloid scoring feature is a method to standardise beta-amyloid plaque quantification in PET scans across various radiopharmaceuticals. The second feature focuses on tau PET ...

Plasma eMTBR-tau243 shows a strong correlation with tau pathology and cognitive decline, offering a less invasive alternative to tau-PET imaging. Study: Plasma MTBR-tau243 biomarker identifies tau ...

Researchers prospectively collected blood samples from 10 individuals who were tau-PET positive, as well as from 22 age-matched healthy individuals, at four global sites. They then used Sunbird ...

Tau imaging with 18F-Flortaucipir PET in Alzheimer’s disease. The figure shows a prototypical tau accumulation pattern, obtained by comparing tau load of patients with Alzheimer’s disease vs ...

Tau imaging with 18F-Flortaucipir PET in Alzheimer’s disease. The figure shows a prototypical tau accumulation pattern, obtained by comparing tau load of patients with Alzheimer’s disease vs ...